Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 7
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
7| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10052313 | VIZZaceclidine hydrochloride | product | Mar 2034 |
| 11179328 | VIZZaceclidine hydrochloride | use | Mar 2034 |
| 9844537 | VIZZaceclidine hydrochloride | product | Mar 2034 |
| 12653779 | VIZZaceclidine hydrochloride | use | Jun 2035 |
| 12128036 | VIZZaceclidine hydrochloride | use | Oct 2039 |
| 12533347 | VIZZaceclidine hydrochloride | use | Oct 2039 |
| 12414942 | VIZZaceclidine hydrochloride | use | Mar 2044 |
| Product | Exclusivity | Until |
|---|---|---|
| VIZZACECLIDINE HYDROCHLORIDE | NCE New chemical entity | Jul 2030 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| VIZZ | Aceclidine | solution/ drops, ophthalmic | 84226-100NDA |
Enquiry
Common questions
- Is LENZ Therapeutics, Inc. FDA approved?
- LENZ Therapeutics, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does LENZ Therapeutics, Inc. make?
- 1 product is listed under LENZ Therapeutics, Inc. in the openFDA NDC Directory, most often as solution/ drops. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.